GB2162843B - Piperazine derivatives - Google Patents

Piperazine derivatives

Info

Publication number
GB2162843B
GB2162843B GB08518452A GB8518452A GB2162843B GB 2162843 B GB2162843 B GB 2162843B GB 08518452 A GB08518452 A GB 08518452A GB 8518452 A GB8518452 A GB 8518452A GB 2162843 B GB2162843 B GB 2162843B
Authority
GB
United Kingdom
Prior art keywords
piperazine derivatives
piperazine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08518452A
Other versions
GB8518452D0 (en
GB2162843A (en
Inventor
Joseph P Yevich
Ronald J Mattson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GB8518452D0 publication Critical patent/GB8518452D0/en
Publication of GB2162843A publication Critical patent/GB2162843A/en
Application granted granted Critical
Publication of GB2162843B publication Critical patent/GB2162843B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB08518452A 1984-07-23 1985-07-22 Piperazine derivatives Expired GB2162843B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63337184A 1984-07-23 1984-07-23

Publications (3)

Publication Number Publication Date
GB8518452D0 GB8518452D0 (en) 1985-08-29
GB2162843A GB2162843A (en) 1986-02-12
GB2162843B true GB2162843B (en) 1988-04-20

Family

ID=24539376

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08518452A Expired GB2162843B (en) 1984-07-23 1985-07-22 Piperazine derivatives

Country Status (8)

Country Link
JP (1) JPS61106570A (en)
CA (1) CA1250291A (en)
DK (1) DK333485A (en)
FR (1) FR2567886B1 (en)
GB (1) GB2162843B (en)
HU (1) HU194874B (en)
IT (1) IT1187699B (en)
SE (1) SE463715B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322199C (en) * 1987-07-15 1993-09-14 Masami Eigyo N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia
KR0173310B1 (en) * 1989-04-22 1999-02-01 폴 에이 리쳐 Piperazine derivatives, their preparation method and pharmaceutical composition comprising thereof
US5340812A (en) * 1989-04-22 1994-08-23 John Wyeth & Brother, Limited Piperazine derivatives
US5250528A (en) * 1989-08-02 1993-10-05 Fujisawa Pharmaceutical Co., Ltd. New aminopiperazine derivatives
GB8917687D0 (en) * 1989-08-02 1989-09-20 Fujisawa Pharmaceutical Co Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
EP1043320A4 (en) * 1997-10-09 2000-12-06 Fujisawa Pharmaceutical Co New process for producing aminopiperazine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (en) * 1969-11-24 1971-05-24 Bristol Myers Co HETEROCYCLICAL AZASPIRODECANEDIONES AND METHODS FOR THEIR PREPARATION
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts

Also Published As

Publication number Publication date
DK333485D0 (en) 1985-07-22
FR2567886A1 (en) 1986-01-24
SE8503557D0 (en) 1985-07-22
HU194874B (en) 1988-03-28
SE463715B (en) 1991-01-14
FR2567886B1 (en) 1988-03-25
CA1250291A (en) 1989-02-21
IT1187699B (en) 1987-12-23
GB8518452D0 (en) 1985-08-29
GB2162843A (en) 1986-02-12
HUT38342A (en) 1986-05-28
IT8521657A0 (en) 1985-07-22
JPS61106570A (en) 1986-05-24
SE8503557L (en) 1986-01-24
DK333485A (en) 1986-01-24

Similar Documents

Publication Publication Date Title
GB2163432B (en) Piperazine derivatives
GB2146333B (en) Piperazine derivatives
GB2157685B (en) Piperazine derivatives
GB2163150B (en) 3-aminopropoxyaryl derivatives
EP0163324A3 (en) Aminoalkylphenoxy derivatives
GB2155925B (en) Pyrimidylpiperazine derivatives
GB2164644B (en) Benzonorbornene derivatives
DE3565267D1 (en) 9a-aza-9a-homoerythromycin derivatives
GB2143235B (en) 1-pyridyl-alkyl-4-aryl piperazine derivatives
GB2159814B (en) Iminothiazolidine derivatives
GB2162843B (en) Piperazine derivatives
ZA858185B (en) New 2-cyanobenzimidazole derivatives
GB2165247B (en) Azabicycloheptene derivatives
GB2162178B (en) 4-cyano-3-oxo-hexahydro-isoquinoline derivatives
DE3570873D1 (en) Piperazine derivative
GB8419223D0 (en) Sulphamoylguanidine derivatives
EP0174271A3 (en) Anthraceme derivatives
GB2153827B (en) New phenylpropargylamine derivatives
GB2158066B (en) Apovincaminol derivatives
GB8422379D0 (en) Derivatives
DE3566257D1 (en) Piperazine derivatives
GB2169892B (en) Piperazine derivatives
GB2169290B (en) Pyrone -3- carboxamide derivatives
ZA859602B (en) New piperazine derivatives
GB8401010D0 (en) Thioketene derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee